CLASS II Device recall · Reported 31 Jul 2013 · FDA Enforcement Report

BD BBL Vancomycin Screen Agar, carton of 10 plates recalled

Becton Dickinson & is recalling BD BBL Vancomycin Screen Agar, carton of 10 plates, distributed nationwide in the US. The recall was initiated on 6 Jun 2013 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot 3081136 Exp June 18, 2013 Lot 3073114 Exp June 12, 2013
Quantity recalled911 cartons

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1798-2013
FDA event ID
65614
Recalling firm
Becton Dickinson &, Sparks, MD
Classification
Class II
Status
Terminated
Recall initiated
6 Jun 2013
FDA classified
24 Jul 2013
Reported
31 Jul 2013
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

6 Jun 2013Recall initiated by company
24 Jul 2013Classified by FDA+48 days
31 Jul 2013Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Microbiological identification media may exhibit reduced levels of Vancomycin.

Product as listed by the FDA

BD BBL Vancomycin Screen Agar, carton of 10 plates, catalog # 222204, labeled in part ***Becton, Dickinson and Company 7 Loveton Circle Sparks, MD 21152 USA 800-638-8663 www.bd.com/ds*** Vancomycin Screen Agar is used to test entercocci for resistance to vancomycin and to predict the synergistic activity of this antimicrobial with an aminoglycoside antimicrobial.

Where it was distributed

Worldwide distribution: US (nationwide) and countries of:Belgium, Canada, Columbia, Mexico, Singapore, and Taiwan.

Nationwide

Questions about this recall

Is BD BBL Vancomycin Screen Agar, carton of 10 plates recalled?

Yes. Becton Dickinson & recalled BD BBL Vancomycin Screen Agar, carton of 10 plates on 6 Jun 2013. The recall is Class II and its status is Terminated. Recall number Z-1798-2013.

Why was it recalled?

Microbiological identification media may exhibit reduced levels of Vancomycin.

Which lots are affected?

Lot 3081136 Exp June 18, 2013 Lot 3073114 Exp June 12, 2013

Where was it sold?

Worldwide distribution: US (nationwide) and countries of:Belgium, Canada, Columbia, Mexico, Singapore, and Taiwan.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Becton Dickinson &

All 361

Other Other Medical Devices recalls

All 13,778